Accelemed Competitors or Alternatives

Accelemed's top competitors include JSS Medical Research, Proxima and ProPharma.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Accelemed's company profile

Anvi Ta

CEO

90/100
25 - 100
$0
$100K - 5M
1
Accelemed's Competitor - JSS Medical Research logo

John S. Sampalis

CEO

90/100
250 - 500
- -
$25M - 100M
2
Accelemed's Competitor - Proxima logo

Kevin Coker

Co-Founder & CEO

98/100
25 - 100
$350K
$5M - 25M
3
Accelemed's Competitor - ProPharma logo

Dawn Sherman

CEO

- -
1,000 - 5,000
- -
$100M - 500M
4
Accelemed's Competitor - Scimega logo

CEO

- -
100 - 250
- -
$25M - 100M
5
Accelemed's Competitor - NCGS logo

CEO

- -
250 - 500
$1M
$5M - 25M

Accelemed VS JSS Medical Research

JSS Medical Research is seen as one of Accelemed's top competitors. JSS Medical Research's headquarters is in St. Laurent, Quebec, and was founded in 1985. Like Accelemed, JSS Medical Research also works within the Health Care Equipment & Services industry. JSS Medical Research generates 1,160% of Accelemed's revenue.

Accelemed VS Proxima

Proxima is one of Accelemed's top rivals. Proxima was founded in 2017, and its headquarters is in Houston, Texas. Like Accelemed, Proxima also works within the Health Care Equipment & Services field. Proxima has 10 more employees than Accelemed.

Accelemed VS ProPharma

ProPharma is Accelemed's #3 rival. ProPharma is a Private company that was founded in 2001 in Raleigh, North Carolina. Like Accelemed, ProPharma also competes in the Health Care Equipment & Services sector. Compared to Accelemed, ProPharma has 2,950 more employees.

Frequently Asked Questions about Accelemed

  1. Who are Accelemed's top competitors?

    Accelemed's top 3 competitors are JSS Medical Research, Proxima, ProPharma.
  2. Who is similar to Accelemed?

    JSS Medical Research is the most similar to Accelemed. Proxima and ProPharma are also similar to Accelemed.
  1. Are Accelemed and JSS Medical Research competitors?

    Yes, JSS Medical Research is one of Accelemed’s top competitors.